Investor
Centre

Fiji Kava (ASX:FIJ) is a kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry. The Company has complete control over its vertically integrated supply chain in a true farm-to-shelf operation and has established a 111-acre nucleus farm in Levuka, on the island of Ovalau, Fiji.

The Company is focused on expanding the distribution of kava throughout western markets to provide a natural alternative to anti-anxiety prescription medicines such as Valium and Xanax. The Company sells its range of TGA and FDA compliant “Taki Mai”branded kava products in Fiji and is preparing to launch under the Fiji Kava brand in Australia in early 2019.

%

OF ADULTS SAY THEIR STRESS HAS INCREASED

Stress in America™, 2013 by American Psychological Association

%

SAY MANAGING STRESS IS IMPORTANT

Stress in America™, 2013 by American Psychological Association

%

SAY THEY’RE MANAGING IT WELL

Stress in America™, 2013 by American Psychological Association

%

REPORT THEY AREN’T DOING ENOUGH TO MANAGE THEIR STRESS

Stress in America™, 2013 by American Psychological Association

Fiji Kava is set to bring the natural solution to anxiety in the western culture.

Click here to find out more
(Main Website)

Find out the latest on our Clincal Trials for our Fiji Kava and the depth of our research

Click here to view our latest clinical trials (coming soon)

Keep up to date with everything Fiji Kava

Click here for the latest News Flow for our Company

SEE THE LATEST FROM OUR BLOG
ASX SHARE CODE

FIJ:ASX